GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Octopus Biosafety (STU:OCR) » Definitions » Accounts Receivable

Octopus Biosafety (STU:OCR) Accounts Receivable : €0.00 Mil (As of Jun. 2016)


View and export this data going back to 2019. Start your Free Trial

What is Octopus Biosafety Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Octopus Biosafety's accounts receivables for the quarter that ended in Jun. 2016 was €0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Octopus Biosafety's Net-Net Working Capital per share for the quarter that ended in Jun. 2016 was €-0.11.


Octopus Biosafety Accounts Receivable Historical Data

The historical data trend for Octopus Biosafety's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Octopus Biosafety Accounts Receivable Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15
Accounts Receivable
- -

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16
Accounts Receivable - - -

Octopus Biosafety Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Octopus Biosafety Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Octopus Biosafety's Days Sales Outstanding for the quarter that ended in Jun. 2016 is calculated as:

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Octopus Biosafety's accounts receivable are only considered to be worth 75% of book value:

Octopus Biosafety's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2016 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0+0.75 * 0+0.5 * 0.036-0.258
-0-0)/2.218
=-0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Octopus Biosafety Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Octopus Biosafety's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Octopus Biosafety (STU:OCR) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.

Octopus Biosafety (STU:OCR) Headlines

No Headlines